SCHEMBL6166482

SCHEMBL6166482

CC(C)c1nn(C)c2c1C(=O)CC(C(C)C)C2

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164973 0.83 DHODH (0.36) DHODH
SCHEMBL6167029 0.83 CSNK2A2 (0.39) —
SCHEMBL6163627 0.80 HTT (0.40) DHODH
SCHEMBL6164331 0.78 DHODH (0.34) DHODH
SCHEMBL21663039 0.75 PDE4B (0.31) —
SCHEMBL6769804 0.74 PPARA (0.38) DHODH
SCHEMBL6163901 0.73 SMN1; SMN2 (0.46) DHODH
SCHEMBL6166619 0.72 HTT (0.42) —
SCHEMBL6767259 0.72 SRC (0.40) DHODH
SCHEMBL6165262 0.72 CCNA2 (0.40) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 — — EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 — — US disclosed
Send feedback